Cargando…
Correction: Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
Autores principales: | Müller, Annelieke R., Luijten, Michiel A. J., Haverman, Lotte, de Ranitz-Greven, Wendela L., Janssens, Peter, Rietman, André B., Hoopen, Leontine W.ten, de Graaff, Laura C. G., de Wit, Marie-Claire, Jansen, Anna C., Gipson, Tanjala, Capal, Jamie K., de Vries, Petrus J., van Eeghen, Agnies M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594910/ https://www.ncbi.nlm.nih.gov/pubmed/37872559 http://dx.doi.org/10.1186/s12916-023-03092-2 |
Ejemplares similares
-
Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
por: Müller, Annelieke R., et al.
Publicado: (2023) -
Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives
por: Overwater, Iris E, et al.
Publicado: (2019) -
The long-term effect of mTOR inhibition on lipid and glucose metabolism in tuberous sclerosis complex: data from the Dutch TSC registry
por: Mulder, Femke V. M., et al.
Publicado: (2022) -
Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex
por: Vergeer, Menno, et al.
Publicado: (2019) -
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
por: de Vries, Petrus J., et al.
Publicado: (2023)